Breaking News, Collaborations & Alliances

NEOMED-LABS, GSK Extend Agreement

NEOMED-LABS will develop immunotools, immunochemical assays, and functional assays and undertake project testing for GSK

NEOMED-LABS announced a 3-year extension of their strategic agreement with GSK. Under the terms of this renewed agreement, NEOMED-LABS will develop immunotools (antigens), immunochemical assays as well as functional assays and undertake the clinical testing for several GSK vaccine projects at the clinical stage. NEOMED-LABS is a spin-out from GSK’s Clinical Laboratory Services since April 2015 with a three-year original agreement. Following a successful transition from GSK, NEOMED-LA...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters